E-ISSN 3041-4369
 

Original Article
Online Published: 28 Mar 2025
 


Sero-Prevalence of HIV Among Pregnant Women in Gokana, Rivers State

Owhonka Aleruchi.


Abstract
Aim: This study aimed to determine the seroprevalence of HIV among pregnant women in Gokana Local Government Area, Rivers State, Nigeria.
Methods: A cross-sectional study was conducted between June 1st, 2022, to 31st December 2022, among pregnant women attending antenatal clinics in Gokana Local Government Area. A total of one hundred and ninety-one (191) pregnant women were selected using a stratified random sampling technique. After obtaining informed consent, participants underwent HIV testing using the Determine™ HIV-1/2 test kit with 1 drop (50 µL) of buffer solution. Reactive samples were confirmed using the Uni-Gold™ HIV test kit with 4 drops (120 µL) of buffer. If the Uni-Gold™ test was negative, ELISA was performed for final confirmation. Sociodemographic information and risk factors for HIV transmission were also collected through structured interviews.
Results: The seroprevalence of HIV among pregnant women in Gokana Local Government Area was 3.7% using Uni-GoldTM HIV test. A significant proportion of HIV-positive pregnant women were unaware of their HIV status prior to the study. Access to antenatal care services and knowledge of HIV prevention measures varied among participants.
Conclusion: The seroprevalence of HIV among pregnant women is a matter of concern, highlighting the need for intensified HIV prevention and testing efforts in this region. Strategies should focus on increasing HIV awareness, access to antenatal care, and the promotion of safe practices to reduce the risk of transmission to newborns. Collaborative efforts between healthcare providers, government agencies, and community organizations are crucial in addressing this public health challenge.

Key words: Keywords: HIV, Seroprevalence, Pregnant Women, Gokana Local Government Area, Rivers State, Nigeria, Vertical Transmission, Antenatal Care, Risk Factors


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Owhonka Aleruchi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Owhonka Aleruchi|. Sero-Prevalence of HIV Among Pregnant Women in Gokana, Rivers State. Eu J Microbiol Infect Dis. 2025; 2(1): 32-39. doi:10.5455/EJMID.20250217051645


Web Style

Owhonka Aleruchi|. Sero-Prevalence of HIV Among Pregnant Women in Gokana, Rivers State. https://www.wisdomgale.com/ejmid/?mno=243272 [Access: April 03, 2025]. doi:10.5455/EJMID.20250217051645


AMA (American Medical Association) Style

Owhonka Aleruchi|. Sero-Prevalence of HIV Among Pregnant Women in Gokana, Rivers State. Eu J Microbiol Infect Dis. 2025; 2(1): 32-39. doi:10.5455/EJMID.20250217051645



Vancouver/ICMJE Style

Owhonka Aleruchi|. Sero-Prevalence of HIV Among Pregnant Women in Gokana, Rivers State. Eu J Microbiol Infect Dis. (2025), [cited April 03, 2025]; 2(1): 32-39. doi:10.5455/EJMID.20250217051645



Harvard Style

Owhonka Aleruchi| (2025) Sero-Prevalence of HIV Among Pregnant Women in Gokana, Rivers State. Eu J Microbiol Infect Dis, 2 (1), 32-39. doi:10.5455/EJMID.20250217051645



Turabian Style

Owhonka Aleruchi|. 2025. Sero-Prevalence of HIV Among Pregnant Women in Gokana, Rivers State. European Journal of Microbiology and Infectious Diseases, 2 (1), 32-39. doi:10.5455/EJMID.20250217051645



Chicago Style

Owhonka Aleruchi|. "Sero-Prevalence of HIV Among Pregnant Women in Gokana, Rivers State." European Journal of Microbiology and Infectious Diseases 2 (2025), 32-39. doi:10.5455/EJMID.20250217051645



MLA (The Modern Language Association) Style

Owhonka Aleruchi|. "Sero-Prevalence of HIV Among Pregnant Women in Gokana, Rivers State." European Journal of Microbiology and Infectious Diseases 2.1 (2025), 32-39. Print. doi:10.5455/EJMID.20250217051645



APA (American Psychological Association) Style

Owhonka Aleruchi| (2025) Sero-Prevalence of HIV Among Pregnant Women in Gokana, Rivers State. European Journal of Microbiology and Infectious Diseases, 2 (1), 32-39. doi:10.5455/EJMID.20250217051645